Abstract
The esterification of rac-ibuprofen and rac-ketoprofen with glycerol catalyzed with the commercial biocatalyst Novozym® 435 was investigated at 45 °C with various profen: glycerol molar ratios using 2-propanol as co-solvent in a batch type reaction. The conversion of rac-ibuprofen reached 46%, with an enantiomeric excess towards the S-enantiomer of 42%. When 1:4 ibuprofen:glycerol molar ratio was assayed, 75% of the R-ibuprofen reacted with glycerol towards the monoglyceride with 99% selectivity, which is highly relevant in the field of prodrugs synthesis. The conversion of rac-ketoprofen was lower, 17 % vs. 46 % of rac-ibuprofen, and the esterification afforded both the monoglyceride (70%) and diglyceride (30%) regardless of the ketoprofen:glycerol molar ratio. Investigations of the esterification at molecular level through concentration-modulated infrared spectroscopy, static ATR-FTIR and in situ Raman spectroscopy showed the continuous decay of the species belonging to rac-ibuprofen and glycerol providing further evidences of the reaction. Moreover, the interaction of CALB with ibuprofen modifies the contribution of the ordered structures of the lipase, which might be related with the improved catalytic performance in the esterification of that profen.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.